DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Hanania NA, Feldman G, Zachgo W et al.
The efficacy and safety of the novel long-acting beta2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.
Chest 2012;
142: 119-127
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.